Page last updated: 2024-10-28

lidocaine and Hepatic Encephalopathy

lidocaine has been researched along with Hepatic Encephalopathy in 5 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research Excerpts

ExcerptRelevanceReference
"Lidocaine (LID) is an aminoethylamide used in hepatology to perform the monoethylglycinexylidide (MEGX) test for the evaluation of liver function in patients with cirrhosis (CIR) or chronic hepatitis (CH)."7.70The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis. ( Botta, F; Fasoli, A; Giannini, E; Risso, D; Romagnoli, P; Testa, R, 2000)
"Lidocaine (LID) is an aminoethylamide used in hepatology to perform the monoethylglycinexylidide (MEGX) test for the evaluation of liver function in patients with cirrhosis (CIR) or chronic hepatitis (CH)."3.70The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis. ( Botta, F; Fasoli, A; Giannini, E; Risso, D; Romagnoli, P; Testa, R, 2000)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jauregui, HO1
Mullon, CJ1
Trenkler, D1
Naik, S1
Santangini, H1
Press, P1
Muller, TE1
Solomon, BA1
Botta, F1
Giannini, E1
Fasoli, A1
Romagnoli, P1
Risso, D1
Testa, R1
Maragos, GD1
Stremmel, W1
Wojdat, R1
Groteguth, R1
Zoedler, M1
Ebener, T1
Niederau, C1
Becker, H1
Strohmeyer, G1
Mainous, EG1
Boyne, J1

Other Studies

5 other studies available for lidocaine and Hepatic Encephalopathy

ArticleYear
In vivo evaluation of a hollow fiber liver assist device.
    Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:2

    Topics: Animals; Artificial Organs; Diazepam; Evaluation Studies as Topic; Extracorporeal Circulation; Galac

1995
The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:4

    Topics: Adult; Aged; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lidocaine; Liver Cirrhosis;

2000
The unconscious child.
    Paediatrician, 1978, Volume: 7, Issue:4-5

    Topics: Atropine; Bicarbonates; Calcium; Child; Coma; Critical Care; Diabetic Coma; Dopamine; Epinephrine; H

1978
[Liver function tests in a clinical comparison].
    Zeitschrift fur Gastroenterologie, 1992, Volume: 30, Issue:11

    Topics: Cholinesterases; Factor V; Factor VII; Galactose; Hepatic Encephalopathy; Humans; Indocyanine Green;

1992
Hepatic coma after multiple dental extractions: report of case.
    Journal of oral surgery (American Dental Association : 1965), 1974, Volume: 32, Issue:9

    Topics: Anesthesia, Local; Anti-Bacterial Agents; Epinephrine; Hepatic Encephalopathy; Humans; Hypnotics and

1974